Crinetics (CRNX) director receives RSU and stock option grants as board pay
Rhea-AI Filing Summary
Crinetics Pharmaceuticals director Stephanie Okey received new equity awards as board compensation. She was granted 5,925 restricted stock units representing future common shares and a stock option for 9,730 shares at an exercise price of $35.87 per share. The restricted stock units and option vest 100% on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, contingent on her continued board service. Following the grant, she holds 12,325 shares of common stock directly.
Positive
- None.
Negative
- None.
Insights
Routine director equity grants add exposure but are not a trading signal.
Crinetics Pharmaceuticals granted director Stephanie Okey 5,925 restricted stock units and options on 9,730 shares at an exercise price of $35.87. These awards are standard board compensation rather than open-market buying.
The awards vest in full on the earlier of the first grant anniversary or the next annual stockholder meeting, subject to continued board service. Because they are compensation grants with no cash outlay and no immediate sale, they carry limited information about short-term expectations.
After the grant, Okey directly holds 12,325 common shares and has the newly awarded options outstanding until their expiration in 2036. Future company filings may detail any exercises or sales if and when they occur.
Insider Trade Summary
Net Buyer: 5,925 shares
Net Buy
2 txns
Insider
Okey Stephanie
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 9,730 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 5,925 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 9,730 shares (Direct);
Common Stock — 12,325 shares (Direct)
Footnotes (2)
- F1. The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
- F2. The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
Key Figures
Restricted stock units granted: 5,925 units
Stock options granted: 9,730 options
Option exercise price: $35.87 per share
+3 more
6 metrics
Restricted stock units granted
5,925 units
Equity award to director on June 18, 2026
Stock options granted
9,730 options
Right to buy common stock granted June 18, 2026
Option exercise price
$35.87 per share
Strike price for 9,730-share option grant
Option expiration
June 18, 2036
Expiration date for stock option grant
Shares owned after grant
12,325 shares
Director’s direct common stock holdings post-transaction
RSU vesting trigger
1 year or next annual meeting
Earlier of grant anniversary or next stockholder meeting
Key Terms
restricted stock units, stock option, exercise price, vesting, +1 more
5 terms
restricted stock units financial
"involves the receipt of restricted stock units, which represent the right to receive shares"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
stock option financial
"The stock option shall vest and become exercisable on the earlier of"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"Stock Option (Right to Buy) with a conversion or exercise price of 35.8700"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"with 100% vesting on the earlier of (a) the first anniversary of the grant date"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
annual meeting of the Issuer's stockholders financial
"the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity awards did Stephanie Okey receive from Crinetics Pharmaceuticals (CRNX)?
Stephanie Okey received 5,925 restricted stock units and a stock option for 9,730 shares of Crinetics Pharmaceuticals common stock at an exercise price of $35.87. These awards are part of her compensation for serving on the company’s board of directors.
How do the new restricted stock units for CRNX director Stephanie Okey vest?
The 5,925 restricted stock units vest 100% on the earlier of the first anniversary of the grant date or the next annual meeting of Crinetics stockholders. Vesting is conditioned on Stephanie Okey continuing to serve on the company’s board through that vesting date.
What are the key terms of Stephanie Okey’s new Crinetics stock options?
Stephanie Okey received stock options for 9,730 shares of Crinetics common stock with a $35.87 exercise price. The options vest in full on the earlier of the first anniversary of the grant date or the next annual stockholder meeting and expire in 2036 if not exercised.
Is Stephanie Okey’s Form 4 transaction in CRNX an open-market purchase or sale?
The Form 4 shows compensation-related equity grants, not open-market trades. Stephanie Okey acquired 5,925 restricted stock units and options for 9,730 shares at $35.87 as board compensation, with no reported open-market buying or selling of Crinetics common stock in this filing.
When will Stephanie Okey’s new Crinetics equity awards fully vest?
Both the 5,925 restricted stock units and the 9,730-share stock option vest fully on the earlier of the first anniversary of the grant date or the next annual meeting of Crinetics stockholders, assuming Stephanie Okey continues serving on the board until that vesting event.